journal
MENU ▼
Read by QxMD icon Read
search

Visceral Medicine

journal
https://www.readbyqxmd.com/read/30345290/inguinal-lymph-node-metastasis-of-a-primary-serous-papillary-carcinoma-of-the-peritoneum-one-year-after-crs-and-hipec
#1
Shadi Katou, Mathilde Feist, Wieland Raue, Johann Pratschke, Beate Rau, Andreas Brandl
Background: Primary peritoneal serous papillary carcinoma is a rare malignant epithelial tumor which was first described in 1959. Peritoneal serous papillary carcinoma arises from the peritoneal epithelium and originates from a single or multicentric focus of the peritoneum involving the peritoneum of the abdomen and pelvis. The involvement of retroperitoneal lymph nodes occurs in 64% of the patients diagnosed with this malignancy. So far, there is no report about inguinal lymph node metastasis in this disease...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345289/overstaging-a-challenge-in-rectal-cancer-treatment
#2
Jan Scheele, Stefan Andreas Schmidt, Sandra Tenzer, Doris Henne-Bruns, Marko Kornmann
Background: Preoperative staging, including computed tomography (CT), magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS), is decisive to envisage the therapeutic concept for rectal cancer (RC). Overstaging may subject the patient to neoadjuvant therapy that does not improve survival but may lead to therapy-associated morbidity. Methods: This study retrospectively compares and values EUS, CT, and MRI in Union Internationale Contre le Cancer (UICC) stage I-III RC with a focus on overstaging...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345288/acute-on-chronic-liver-failure
#3
REVIEW
Christian M Lange, Wolf Otto Bechstein, Thomas Berg, Cornelius Engelmann, Tony Bruns, Ali Canbay, Richard Moreau, Jonel Trebicka
No abstract text is available yet for this article.
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345287/liver-transplantation-in-acute-on-chronic-liver-failure-considerations-for-a-systematic-approach-to-decision-making
#4
REVIEW
Michael Heise, Nina Weiler, Sonja Iken, Martin-Walter Welker, Stefan Zeuzem, Wolf O Bechstein, Andreas A Schnitzbauer
Background: Acute-on-chronic liver failure (ACLF) is a complex disease with deteriorating liver and kidney function and associated organ failure in patients with chronic liver disease. Methods: This is a concise overview for bedside and algorithmic decision making in patients with ACLF based on the most recent literature. Results: Diagnosis and dynamics of ACLF can be easily monitored with the CLIF-C-ACLF calculator, which delivers grading for ACLF and estimates the risk of mortality, as the natural transplant-free course of ACLF is often fatal...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345286/intensive-care-therapy-for-patients-with-advanced-liver-diseases
#5
REVIEW
Antonios Katsounas, Ali Canbay
Decompensated cirrhosis is characterized by high hospitalization rates and costs, frequent readmissions, and poor short-term survival. Patients admitted to the hospital with acute variceal bleeding and/or hepatic encephalopathy and/or renal dysfunction are at serious risk for developing infection and/or sepsis; in turn, this renders them highly susceptible to the development of multi-system organ failure. The lack of standardized intensive care unit management protocols in patients with cirrhosis along with only few data reports from longitudinal clinical trials makes it difficult for hepatologists and critical care specialists to provide uniform evidence for clinical practice that could safely consolidate favorable outcomes such as lower hospitalization rates and/or mortality...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345285/immunodysfunction-in-acute-on-chronic-liver-failure
#6
REVIEW
Christian M Lange, Richard Moreau
Background: Increasing evidence reveals a close and reciprocal link between acute-on-chronic liver failure (ACLF) and immunodysfunction. Methods: A literature search in PubMed and abstract databases of relevant congresses was performed. Results: Important characteristics of liver cirrhosis like tissue hypoxia, cell death, or bacterial translocation maintain a state of chronic inflammation. Precipitating events of ACLF such as infections or alcoholic hepatitis are capable of strongly augmenting cirrhosis-associated systemic inflammation to grades sufficient to induce ACLF-defining organ failures...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345284/gut-liver-axis-links-portal-hypertension-to-acute-on-chronic-liver-failure
#7
REVIEW
Jonel Trebicka, Thomas Reiberger, Wim Laleman
Acute-on-chronic liver failure (ACLF) is considered a distinct syndrome in patients with liver disease, with systemic inflammation playing a central role. Portal hypertension (PHT) is also aggravated by inflammation and may subsequently impact the course of ACLF. PHT is more than just an increase in portal pressure in the portal venous system; it aggravates the course of liver disease and, thus, also facilitates the development of acute decompensation and ACLF. A critical mechanistic link between PHT and ACLF might be the gut-liver axis, which is discussed in this review...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345283/management-of-infectious-complications-associated-with-acute-on-chronic-liver-failure
#8
REVIEW
Cornelius Engelmann, Thomas Berg
Introduction: Acute-on-chronic liver failure (ACLF) is associated with a high susceptibility to infections leading to complications and poor prognosis. The sensitized immune system overwhelmingly responds to invading bacteria leading to organ damage. After resolution of infection or prolonged disease duration, the phagocytic system becomes irresponsive with a reduced bacterial clearance capacity promoting secondary infection. Methods: This review focuses on the best management strategies for patients with ACLF and infections...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345282/management-of-coagulopathy-during-bleeding-and-invasive-procedures-in-patients-with-liver-failure
#9
REVIEW
Andreas Drolz, Arnulf Ferlitsch, Valentin Fuhrmann
Alterations in hemostasis are a characteristic feature of advanced liver disease. Patients with coagulopathy of advanced liver disease are prone to bleedings and also thromboembolic events. Under stable conditions, cirrhosis patients show alterations in both pro- and anticoagulatory pathways, frequently resulting in a rebalanced hemostasis. This review summarizes current recommendations of management during bleeding and prior to invasive procedures in patients with cirrhosis.
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345281/renal-failure-in-patients-with-liver-cirrhosis-novel-classifications-biomarkers-treatment
#10
REVIEW
Beate Appenrodt, Frank Lammert
Renal failure is a severe complication in patients with liver cirrhosis. It is associated with increased mortality and morbidity. Diagnosis is a challenge because it is mainly based on serum creatinine, which does not seem to be an ideal measure of renal function in cirrhosis. The definition of renal failure in these patients has been changed for optimizing treatment and for improving outcome and prognosis. The new criteria are based on the adapted KDIGO (Kidney Disease: Improving Global Outcomes) staging system...
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30345280/acute-on-chronic-liver-failure
#11
EDITORIAL
Wolf O Bechstein, Stefan Zeuzem
No abstract text is available yet for this article.
August 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30182025/surgery-of-cystic-tumors-of-the-pancreas-why-when-and-how
#12
REVIEW
Jan G D'Haese, Jens Werner
The management of cystic pancreatic neoplasms has increasingly gained clinical attention due to their frequent incidental detection by cross-sectional imaging and their potential for progression to pancreatic cancer. Surgical resection is warranted for all mucinous cystic neoplasms, solid pseudopapillary neoplasms, and main-duct intraductal papillary mucinous neoplasms since these lesions harbor a major risk for malignant transformation. For branch-duct IPMN (BD-IPMN), the risk for malignancy is considerably lower so that some lesions may be safely followed while others require surgical resection...
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30182024/pancreatic-cystic-neoplasms-different-types-different-management-new-guidelines
#13
REVIEW
Lianne Scholten, Nadine C M van Huijgevoort, Jeanin E van Hooft, Marc G Besselink, Marco Del Chiaro
Pancreatic cystic neoplasms (PCN) include different types of cysts with various biological behavior. The most prevalent PCN are intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN), and serous cystic neoplasm (SCN). Management of PCN should focus on the prevention of malignant progression, while avoiding unnecessary morbidity of surgery. This requires specialized centers with dedicated multidisciplinary PCN teams. The malignant potential of PCN varies enormously between the various types of PCN...
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30140689/fatal-case-of-spontaneous-rectus-sheath-hematoma-caused-by-anticoagulant-and-steroid-therapy-during-hospital-admission
#14
Ivan Romic, Goran Pavlek, Marko Mance, Marijan Romic, Trpimir Moric
Background: Rectus sheath hematoma (RSH) is a rare but potentially dangerous clinical entity that requires medical supervision. Case Report: Here we discuss one such case which describes the fatal course of spontaneous RSH during hospital admission. Conclusion: Usually, RSH presents as a minimal abdominal wall swelling with self-limiting course but in the case of hematoma and size progression, specific conservative or invasive measures are necessary to prevent serious complications including hypovolemic shock and death...
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30140688/the-ongoing-challenge-of-acute-mesenteric-ischemia
#15
REVIEW
Bernd Luther, Apostolos Mamopoulos, Christian Lehmann, Ernst Klar
Background: The lethality of acute mesenteric ischemia (AMI) remains quite high with 50-70%. The main reasons for that are the fact that AMI is rarely taken into consideration by the differential diagnosis of acute abdomen, the time-consuming diagnostic process, and the lack of a standardized therapeutic concept. The present interdisciplinary review aims to increase awareness among physicians and to help improve clinical outcomes. Methods: This clinical therapeutic review is based on author expertise as well as a selective literature survey in PubMed based on the term 'mesenteric ischemia', combined with the terms 'arterial', 'clinical presentation', 'diagnosis', 'therapy', 'surgery', and 'interventional radiology'...
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30140687/diagnostic-and-treatment-algorithms-of-pancreatic-cystic-tumors
#16
Jens Werner, Orlin Belyaev, Carlos Fernández-Del Castillo, Philippe Lévy, Matthias Löhr, Julia Mayerle, Waldemar Uhl
No abstract text is available yet for this article.
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30140686/surveillance-of-cystic-lesions-of-the-pancreas-whom-and-how-to-survey
#17
REVIEW
Stefano Andrianello, Massimo Falconi, Roberto Salvia, Stefano Crippa, Giovanni Marchegiani
The sudden prevalence increase of pancreatic cystic neoplasms (PCN) related to the use of cross-sectional imaging has raised several concerns. Even if there is a tangible risk of progression towards pancreatic cancer (PC), surgical resection cannot be offered to all patients due to the high risk of morbidity and mortality. Available guidelines are useful tools to identify patients at higher risk for harboring cancer thanks to their sensitivity. Because of their low specificity, however, such a risk is often overestimated...
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30140685/management-algorithm-for-cystic-pancreatic-lesions
#18
REVIEW
Georg Beyer, Elisabetta Goni, Marlies Köpke, Jan G D'Haese, Jens Werner, Jörg Schirra, Julia Mayerle
Cystic pancreatic lesions are common findings in an aging society due to an increasing availability of high-resolution cross-sectional imaging. Although the overall prevalence of malignancy and the rate of malignant conversion are low, especially mucinous pancreatic cystic lesions such as intraductal papillary mucinous neoplasm and mucinous cystic neoplasm harbor significant malignant potential depending on their morphology and size. Recently updated guidelines recommend sophisticated algorithms for initial workup and surveillance based on individual characteristics of the cystic lesion and the patient, thus weighing the lifetime risk for malignancy against the adverse event rate of potentially curative surgery in the light of number and location of cystic lesions, age of the patient, comorbidities, and the resulting life expectancy as well as the effect of repeated follow-up examinations on the patient's quality of life...
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30140684/the-role-of-endoscopic-ultrasound-in-the-diagnosis-of-cystic-lesions-of-the-pancreas
#19
REVIEW
Philippe Lévy, Vinciane Rebours
A precise diagnosis of the nature of pancreatic cystic neoplasm (PCN) is crucial since it determines the patients in need of rapid surgical resection as well as those who can be followed up, and, accordingly, the frequency and modalities of surveillance. Endoscopic ultrasound (EUS) and especially fine needle aspiration (FNA) are invasive methods, with specific adverse events occurring in 2.7-5%. Thus, they should only be used as a third-line tool in the absence of characteristic radiographic features on computed tomography (CT) scan and magnetic resonance imaging (MRI)...
July 2018: Visceral Medicine
https://www.readbyqxmd.com/read/30140683/radiological-workup-of-cystic-neoplasms-of-the-pancreas
#20
REVIEW
Thomas L Bollen, Frank J Wessels
Pancreatic cystic lesions are being detected with increasing frequency because of increased use and improved quality of cross-sectional imaging techniques. Pancreatic cystic lesions encompass non-neoplastic lesions (such as pancreatitis-related collections) and neoplastic tumors. Common cystic pancreatic neoplasms include serous cystadenomas, mucinous cystic neoplasms, intraductal papillary mucinous neoplasms, and solid pseudopapillary tumors. These cystic pancreatic neoplasms may have typical morphology, but at times show overlapping imaging features on cross-sectional examinations...
July 2018: Visceral Medicine
journal
journal
53423
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"